Identification of chromosomal changes with comparative genomic hybridization in sporadic breast cancer in Mexican women

Cancer Genetics and Cytogenetics

Volumn 152, Issue 2, 2004, Pages 163-166

  Valladares, Adán ^a,b   Salamanca, Fabio ^a   Madrigal Bujaidar, Eduardo ^b   Arenas, Diego ^a  

^a Ctro Medico Nac Siglo XXI I   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER STAGING; CHROMOSOME 12P; CHROMOSOME 13Q; CHROMOSOME 16P; CHROMOSOME 19P; CHROMOSOME 1P; CHROMOSOME 2P; CHROMOSOME 5Q; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CHROMOSOME XP; CHROMOSOME XQ; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MEXICO; PANCREAS CANCER; PRIORITY JOURNAL; STOMACH CANCER; TESTIS TUMOR;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHROMOSOME ABERRATIONS; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MEXICO; MIDDLE AGED; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION; WOMEN;

EID: 3242673301     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.11.016     Document Type: Article

References (28)

1. Gupta D., Middleton L.P., Whitaker M.J., Abrams J. Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene in breast cancer. Am J Clin Pathol. 119:2003;381-387
2. Ioannidis P., Mahaira L., Papadopoulou A., Teixeira M.R., Heim S., Andersen J.A., Evangelou E., Dafni U., Pandis N., Trangas T. 8q24 copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas. Int J Cancer. 10:2003;54-59
3. Hyman E., Kauraniemi P., Hautaniemi S., Wolf M., Mousses S., Rozenblum E., Ringner M., Sauter G., Monni O., Elkahloun A., Kallioniemi O.P., Kallioniemi A. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res. 62:2002;6240-6245
4. Bekri S., Adelaide J., Merscher S., Grosgeorge J., Caroli-Bosc F., Perucca-Lostanlen D., Kelley P.M., Pebusque M.J., Theillet C., Birnbaum D., Gaudray P. Detailed map of a region commonly amplified at 11q13→q14 in human breast carcinoma. Cytogenet Cell Genet. 79:1997;125-131
5. Forazan F., Mahlamaki E.H., Monni O. Comparative genomic hybridization analysis of 38 breast cancer cell: a basis for interpreting complementary DNA microarray data. Cancer Res. 60:2000;4519-4525
6. Daigo Y., Feung C.S., Gorringe L.K., Bobrow G.L., Ponder J.A.B., Pharoah P., Caldas C. Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancer. Am J Pathol. 158:2001;1623-1631
7. Kempter B. Quick preparation of high molecular weight DNA by freezing. Trends Genet. 8:1992;7-8
8. Knuutila S., Autio K., Aalto Y. Online access to CGH data of DNA sequence copy number changes. Am J Pathol. 157:2000;689
9. Hislop R.G., Pratt N., Stocks S.C., Steel C.M., Sales M., Goudi D., Robertson A., Thompson A.M. Karyotypic aberrations of chromosome 16 and 17 are related to survival in patients with breast cancer. Br J Surg. 89:2002;1581-1586
10. Aubele M., Auer G., Braselmann H., Nahring J., Zitzelsberger H., Quintanilla M.L., Smida J., Walch A., Hofler H., Werner M. Chromosomal imbalances are associated with metastasis-free survival in breast cancer patients. Anal Cell Pathol. 24:2002;77-87
11. Nagasaki K., Manabe T., Hanzawa H., Maas N., Tsukada T., Yamaguchi K. Identification of a novel gene, LDOC1, down-regulated in cancer cell lines. Cancer Lett. 140:1999;227-234
12. Rapley E.A., Crockford G.P., Teare D., Biggs P., Seal S., Barfoot R., Edwards S., Hamoudi R., Heimdal K., Fossa S.D., Tucker K., Donald J., Collins F., Friedlander M., Hogg D., Goss P., Heidenreich A., Ormiston W., Daly P.A., Forman D., Oliver T.D., Leahy M., Huddart R., Cooper C.S., Bodmer J.G., Easton D.F., Stratton M.R., Bishop D.T. Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet. 24:2000;197-200
13. Ollendorff V., Noguchi T., deLapeyriere O., Birnbaum D. The GARP gene encodes a new member of the family of leucine-rich repeat-containing proteins. Cell Growth Differ. 5:1994;213-219
14. Hinds P.W., Dowdy S.F., Eaton E.N., Arnold A., Weinberg R.A. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci U S A. 91:1994;709-713
15. Donnellan R., Chetty R. Cyclin D1 and human neoplasia. Mol Pathol. 51:1998;1-7
16. Kas K., Weber G., Merregaert J., Michiels L., Sandelin K., Skogseid B., Thompson N., Nordenskjold M., Larsson C., Friedman E. Exclusion of FAU as the multiple endocrine neoplasia type 1 (MEN1) gene. Hum Mol Genet. 2:1993;349-353
17. Benharroch D., Birnbaum D. Biology of the fibroblast growth factor gene family. Isr J Med Sci. 26:1990;212-219
18. Bindels E.M., Lallemand F., Balkenende A., Verwoerd D., Michalides R. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells. Oncogene. 21:2002;8158-8165
19. Zheng J.Y., Koda T., Fujigara T., Kishi M., Ikehara Y., Kakinuma M. A novel Rab GTPase, Rab33B, is ubiquitously expressed and localized to the medial Golgi cisternae. J Cell Sci. 111:1998;1061-1069
20. Kainu T., Juo S.H., Desper R., Schaffer A.A., Gillanders E., Rozenblum E., Freas-Lutz D., Weaver D., Stephan D., Bailey-Wilson J., Kallioniemi O.P., Tirkkonen M., Syrjakoski K., Kuukasjarvi T., Koivisto P., Karhu R., Holli K., Arason A., Johannesdottir G., Bergthorsson J.T., Johannsdottir H., Egilsson V., Barkardottir R.B., Johannsson O., Haraldsson K., Sandberg T., Holmberg E., Gronberg H., Olsson H., Borg A., Vehmanen P., Eerola H., Heikkila P., Pyrhonen S., Nevanlinna H. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc Natl Acad Sci U S A. 97:2000;9603-9608
21. Thompson D., Szabo C.I., Mangion J., Oldenburg R.A., Odefrey F., Seal S., Barfoot R., Kroeze J.K., Teare F., Rahman N., Renard H., Mann G., Hopper J.L., Buys S.S., Andrulis I.L., Senie R., Daly M.B., West D., Ostrander E.A., Offit K., Peretz T., Osorio A., Benítez J., Nathanson K.L., Sinilnikova O.M., Olah E., Bignon Y.J., Ruiz P., Badzioch M.D., Vasen H.F., Futreal A.P., Phelan C.M., Narod S.A., Lynch H.T., Ponder B.A., Eeles R.A., Meijers H.H., Stoppa L.D., Couch F.J., Eccles D.M., Evans D.G., Chang C.J., Lenoir G., Weber B.L., Devilee P., Easton D.F., Goldgar D.E., Stratton M.R., the KConFab Consortium. Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proc Natl Acad Sci U S A. 99:2002;827-831
22. National Center for Biotechnology Information. LocusLink. Available at http://www.ncbi.nlm.nih.gov/LocusLink/list.cgi. Accessed June 2004.
23. Yang Q., Yoshimura G., Mori I., Sakurai T., Kakudo K. Chromosome 3p and breast cancer. J Hum Genet. 47:2002;453-459
24. Wolf S.F., Sieburth D., Sypek J. Interleukin 12: a key modulator of immune function. Stem Cells. 12:1994;154-168
25. Wolf S.F., Lee K., Swiniarski H., O'Toole M., Sturmhoefel K. Cytokines and cancer immunotherapy. Immunol Invest. 29:2000;143-146
26. Sun L., Chen C.J. Expression of transforming growth factor beta type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells. Biol Chem. 27:1997;25367-25372
27. Bandyopadhyay A., Zhu Y., Cibull M.L., Bao L., Chen C., Sun L. A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells. Cancer Res. 59:1999;5041-5046
28. Smith M.L., Chen I.T., Zhan Q., Bae I., Chen C.Y., Gilmer T.M., Kastan M.B., O'Connor P.M., Fornace A.J. Jr. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science. 26:1994;1376-1380